National HealthCare (NHC) Financials

$102.33 +0.74 (+0.73%)

As of 05/23/2025 04:10 PM Eastern

Annual Income Statements for National HealthCare

This table shows National HealthCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	102	67	22	139	42	68	59	56	51	46	45
Consolidated Net Income / (Loss)	102	65	20	139	42	68	59	56	51	53	53
Net Income / (Loss) Continuing Operations	102	65	20	139	42	68	59	56	51	53	53
Total Pre-Tax Income	136	89	27	150	52	88	75	75	80	85	85
Total Operating Income	86	57	32	51	48	49	56	54	61	67	68
Total Gross Profit	496	429	400	408	407	404	398	392	376	374	361
Total Revenue	1,307	1,142	1,086	1,074	1,028	996	980	964	924	907	872
Operating Revenue	1,261	1,088	1,041	1,029	979	948	933	917	878	865	829
Other Revenue	46	54	45	45	49	49	48	47	46	42	42
Total Cost of Revenue	811	712	686	666	621	593	583	572	548	533	510
Operating Cost of Revenue	811	712	686	666	621	593	583	572	548	533	510
Total Operating Expenses	411	372	368	357	359	355	342	338	315	307	293
Selling, General & Admin Expense	321	288	289	267	275	268	254	250	231	227	217
Depreciation Expense	42	42	40	41	42	42	42	43	39	37	34
Other Operating Expenses / (Income)	47	42	38	42	42	44	46	45	45	43	42
Total Other Income / (Expense), net	51	32	-4.67	99	4.27	39	19	20	20	18	17
Interest & Investment Income	31	15	-16	81	-22	1.98	-	-	-	-	-
Other Income / (Expense), net	20	17	11	18	27	37	19	20	20	18	17
Income Tax Expense	34	23	7.25	11	10	20	16	19	30	32	32
Net Income / (Loss) Attributable to Noncontrolling Interest	0.16	-1.51	-2.47	0.50	0.12	-0.24	-0.27	-0.52	0.00	0.00	-
Basic Earnings per Share	$6.62	$4.36	$1.46	$9.03	$2.74	$4.47	$3.87	$3.70	$3.34	$3.34	$3.24
Weighted Average Basic Shares Outstanding	15.39M	15.31M	15.41M	15.35M	15.31M	15.27M	15.22M	15.19M	15.13M	13.89M	13.82M
Diluted Earnings per Share	$6.53	$4.34	$1.45	$8.99	$2.72	$4.44	$3.87	$3.69	$3.32	$3.20	$3.14
Weighted Average Diluted Shares Outstanding	15.60M	15.38M	15.45M	15.42M	15.37M	15.36M	15.24M	15.22M	15.21M	14.49M	14.22M
Weighted Average Basic & Diluted Shares Outstanding	15.45M	15.35M	15.36M	15.45M	15.37M	15.33M	15.26M	15.20M	15.10M	13.90M	13.80M
Cash Dividends to Common per Share	$2.42	$2.34	$2.26	$2.11	$2.08	$2.06	$1.98	$1.89	$1.75	$1.54	$1.34

This table shows National HealthCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	32	6.08	43	27	26	28	10	16	12	6.35	-2.43
Consolidated Net Income / (Loss)	32	6.03	43	27	26	28	10	16	11	5.57	-3.11
Net Income / (Loss) Continuing Operations	32	6.03	43	27	26	28	10	16	11	5.57	-3.11
Total Pre-Tax Income	44	6.06	58	37	36	37	14	22	16	7.41	-4.25
Total Operating Income	31	27	21	23	16	20	13	14	10	9.05	4.08
Total Gross Profit	146	135	127	121	114	114	106	107	102	97	98
Total Revenue	374	369	340	301	297	301	288	283	270	265	271
Operating Revenue	362	357	329	289	286	283	277	270	258	253	260
Other Revenue	12	12	12	11	11	18	11	13	12	12	11
Total Cost of Revenue	228	234	213	180	183	187	183	175	168	167	173
Operating Cost of Revenue	228	234	213	180	183	187	183	175	168	167	173
Total Operating Expenses	115	108	106	98	98	94	93	93	92	88	94
Selling, General & Admin Expense	92	83	83	78	77	71	72	73	71	71	73
Depreciation Expense	11	11	11	9.34	11	12	10	10	10	10	10
Other Operating Expenses / (Income)	11	14	13	11	10	11	10	9.99	10	6.59	10
Total Other Income / (Expense), net	13	-21	37	14	20	17	1.00	8.35	5.71	-1.64	-8.33
Interest Expense	2.11	-	-	-	-	-	-	-	-	-	-
Interest & Investment Income	11	-25	33	9.12	14	12	-3.09	4.65	1.39	-4.33	-11
Other Income / (Expense), net	4.08	4.83	4.22	4.96	5.69	4.54	4.10	3.70	4.32	2.69	2.73
Income Tax Expense	11	0.03	15	9.49	9.46	8.70	3.91	6.41	4.44	1.84	-1.14
Net Income / (Loss) Attributable to Noncontrolling Interest	0.09	-0.05	-0.09	0.26	0.04	-0.44	-0.27	-0.36	-0.44	-0.78	-0.68
Basic Earnings per Share	$2.09	$0.39	$2.78	$1.74	$1.71	$1.86	$0.68	$1.06	$0.76	$0.42	($0.16)
Weighted Average Basic Shares Outstanding	15.44M	15.39M	15.41M	15.39M	15.35M	15.31M	15.30M	15.30M	15.34M	15.41M	15.45M
Diluted Earnings per Share	$2.07	$0.38	$2.73	$1.73	$1.69	$1.84	$0.68	$1.06	$0.76	$0.41	($0.16)
Weighted Average Diluted Shares Outstanding	15.58M	15.60M	15.67M	15.56M	15.51M	15.38M	15.32M	15.32M	15.36M	15.45M	15.45M
Weighted Average Basic & Diluted Shares Outstanding	15.47M	15.45M	15.44M	15.42M	15.40M	15.35M	15.32M	15.32M	15.32M	15.36M	15.34M
Cash Dividends to Common per Share	$0.61	$0.61	$0.61	$0.61	$0.59	$0.59	$0.59	$0.59	$0.57	$0.57	$0.57

This table details how cash moves in and out of National HealthCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-29	51	-45	-39	97	6.09	-13	36	-18	-31	-15
Net Cash From Operating Activities	107	111	8.74	62	203	100	98	94	91	83	82
Net Cash From Continuing Operating Activities	107	111	8.74	62	203	100	98	94	91	83	82
Net Income / (Loss) Continuing Operations	102	65	20	139	42	68	59	56	51	53	53
Consolidated Net Income / (Loss)	102	65	20	139	42	68	59	56	51	53	53
Depreciation Expense	42	42	40	41	42	42	42	43	39	37	34
Non-Cash Adjustments To Reconcile Net Income	-32	-19	-0.44	-106	72	-19	-0.16	2.33	1.28	1.90	13
Changes in Operating Assets and Liabilities, net	-5.03	23	-51	-11	47	9.00	-2.00	-6.20	0.04	-8.80	-19
Net Cash From Investing Activities	-237	-18	-5.98	-66	-64	-14	-34	-9.56	-81	-73	-67
Net Cash From Continuing Investing Activities	-237	-18	-5.98	-66	-64	-14	-34	-9.56	-81	-73	-67
Purchase of Property, Plant & Equipment	-28	-28	-30	-39	-22	-26	-30	-32	-63	-58	-53
Acquisitions	-214	-2.70	0.00	-29	-6.65	-16	-0.53	0.00	0.00	-0.67	-1.98
Purchase of Investments	-49	-34	-34	-109	-85	-13	-14	-31	-49	-61	-62
Sale of Property, Plant & Equipment	2.10	0.00	4.18	-	6.75	0.00	4.30	0.00	0.00	-	-
Sale and/or Maturity of Investments	52	47	50	102	43	46	6.09	54	36	53	52
Other Investing Activities, net	-0.01	-0.20	3.88	8.84	-0.43	-5.46	0.00	-0.45	-6.53	-5.68	-1.54
Net Cash From Financing Activities	100	-43	-48	-35	-42	-80	-77	-49	-27	-42	-30
Net Cash From Continuing Financing Activities	100	-43	-48	-35	-42	-80	-77	-49	-27	-42	-30
Repayment of Debt	-13	0.00	0.00	-	-50	-49	-45	-23	-3.28	-3.69	-2.44
Repurchase of Common Equity	-14	-2.48	-9.90	-0.84	-0.05	-0.87	-0.87	0.00	-8.20	0.00	-7.00
Payment of Dividends	-36	-36	-34	-33	-29	-32	-30	-28	-26	-30	-27
Issuance of Debt	150	0.00	0.00	-	40	0.00	0.00	-	-	110	0.00
Issuance of Common Equity	14	0.31	2.11	3.44	1.76	2.35	2.87	3.74	11	11	7.43
Other Financing Activities, net	-1.17	-4.82	-5.50	-4.88	-4.16	-0.62	-4.45	-1.10	-0.64	1.99	-0.75
Cash Interest Paid	3.42	0.29	0.49	0.85	1.43	3.12	4.90	5.18	4.53	2.97	2.24
Cash Income Taxes Paid	18	15	8.77	23	17	21	9.18	24	28	29	37

This table details how cash moves in and out of National HealthCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	19	-18	-51	44	-4.84	5.71	17	28	-0.19	2.67	-19
Net Cash From Operating Activities	39	13	34	51	9.65	26	32	39	14	12	-1.98
Net Cash From Continuing Operating Activities	39	13	34	51	9.65	26	32	39	14	12	-1.98
Net Income / (Loss) Continuing Operations	32	6.03	43	27	26	28	10	16	11	5.57	-3.11
Consolidated Net Income / (Loss)	32	6.03	43	27	26	28	10	16	11	5.57	-3.11
Depreciation Expense	11	11	11	9.34	11	12	10	10	10	10	10
Non-Cash Adjustments To Reconcile Net Income	-11	22	-31	-17	-5.70	-15	3.28	-4.89	-2.06	-8.77	20
Changes in Operating Assets and Liabilities, net	7.46	-27	12	32	-21	1.11	8.77	18	-5.42	4.65	-29
Net Cash From Investing Activities	-7.32	-12	-224	1.43	-2.42	-10	-5.14	-0.82	-1.43	2.83	-0.65
Net Cash From Continuing Investing Activities	-7.32	-12	-224	1.43	-2.42	-10	-5.14	-0.82	-1.43	2.83	-0.65
Purchase of Property, Plant & Equipment	-6.14	-8.16	-5.66	-7.83	-5.96	-8.60	-6.51	-6.15	-6.64	-5.64	-7.53
Purchase of Investments	-13	-16	-9.35	-14	-10	-12	-7.36	-4.13	-10	-5.08	-3.82
Sale and/or Maturity of Investments	12	12	5.11	23	12	11	8.53	13	15	12	7.30
Other Investing Activities, net	0.01	-2.03	0.14	-0.23	2.12	-0.00	0.21	-0.41	0.00	-2.48	3.40
Net Cash From Financing Activities	-13	-19	139	-7.61	-12	-9.83	-9.82	-10	-13	-12	-17
Net Cash From Continuing Financing Activities	-13	-19	139	-7.61	-12	-9.83	-9.82	-10	-13	-12	-17
Repayment of Debt	-3.00	-10	-	-	-	-	-	-	-	3.50	-
Repurchase of Common Equity	-1.72	-	-2.10	-1.50	-9.90	-	-	-	-2.48	-3.00	-6.76
Payment of Dividends	-9.42	-9.69	-8.02	-9.09	-9.05	-9.04	-9.04	-8.73	-8.75	-8.77	-8.83
Issuance of Common Equity	1.28	0.80	2.23	2.83	8.41	0.05	0.25	0.01	0.00	0.83	0.16
Other Financing Activities, net	0.17	-	0.21	0.15	-1.53	-0.85	-1.04	-1.55	-1.39	-4.66	2.18

This table presents National HealthCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	1,524	1,311	1,275	1,403	1,362	1,287	1,081	1,097	1,087	1,045	1,074
Total Current Assets	424	406	354	427	457	341	322	329	291	279	323
Cash & Equivalents	76	107	59	108	147	50	43	59	26	38	70
Restricted Cash	20	57	54	10	31	30	9.97	6.40	26	27	27
Short-Term Investments	175	117	124	196	176	152	159	160	138	116	133
Note & Lease Receivable	0.51	0.50	0.30	0.45	0.93	1.70	1.29	1.45	3.26	0.46	0.44
Accounts Receivable	135	109	100	96	90	93	97	87	83	84	79
Inventories, net	9.04	7.39	7.09	8.58	8.78	7.44	7.47	7.15	7.51	7.57	7.13
Prepaid Expenses	9.06	8.86	10	7.36	2.98	6.64	3.86	2.86	2.65	2.17	2.26
Plant, Property, & Equipment, net	684	493	507	521	520	535	535	549	560	536	515
Plant, Property & Equipment, gross	1,282	1,102	1,081	1,064	1,030	1,017	979	959	933	875	822
Accumulated Depreciation	597	608	575	543	510	482	444	409	374	339	307
Total Noncurrent Assets	416	411	415	456	385	410	224	218	237	230	237
Long-Term Investments	136	126	105	118	166	166	186	182	198	189	176
Goodwill	170	168	168	168	21	21	21	18	18	18	18
Intangible Assets	20	7.04	7.04	7.04	0.00	-	-	-	-	-	-
Other Noncurrent Operating Assets	88	109	133	161	184	208	5.60	4.87	5.24	8.45	8.79
Other Noncurrent Nonoperating Assets	1.23	1.17	1.08	1.73	1.74	1.73	1.71	1.91	2.13	2.31	3.63
Total Liabilities & Shareholders' Equity	1,524	1,311	1,275	1,403	1,362	1,287	1,081	1,097	1,087	1,045	1,074
Total Liabilities	541	400	398	495	564	508	346	393	418	414	340
Total Current Liabilities	235	214	198	263	281	195	158	155	151	151	184
Short-Term Debt	7.50	0.86	4.99	-	4.42	14	3.92	3.70	3.48	3.28	3.09
Accounts Payable	41	38	34	40	38	34	36	33	36	37	39
Accrued Expenses	93	84	73	107	86	70	68	67	66	65	60
Dividends Payable	9.42	9.05	8.75	8.49	7.99	7.97	7.62	7.30	6.82	6.00	7.00
Other Current Liabilities	84	83	78	108	94	69	43	44	39	39	39
Total Noncurrent Liabilities	306	186	200	232	283	313	189	238	267	264	156
Long-Term Debt	130	0.00	-	-	-	-	55	100	120	120	10
Asset Retirement Reserve & Litigation Obligation	73	73	71	67	69	66	67	66	65	71	79
Noncurrent Deferred & Payable Income Tax Liabilities	36	17	11	6.85	14	24	19	18	22	9.10	0.00
Other Noncurrent Operating Liabilities	69	96	117	158	189	207	23	25	26	30	30
Total Equity & Noncontrolling Interests	983	910	878	908	798	779	734	703	670	631	734
Total Preferred & Common Equity	980	909	874	903	795	779	733	703	670	631	734
Total Common Equity	980	909	874	903	795	779	733	703	670	631	564
Common Stock	233	228	227	232	227	223	220	216	212	210	155
Retained Earnings	752	688	657	669	563	553	516	419	392	368	344
Accumulated Other Comprehensive Income / (Loss)	-4.72	-6.60	-9.53	1.61	5.06	2.56	-2.75	68	66	53	65
Noncontrolling Interest	3.00	1.73	3.24	5.46	3.08	0.48	1.18	0.69	0.00	-	-

This table presents National HealthCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,549	1,563	1,340	1,320	1,282	1,281	1,265	1,296
Total Current Assets	455	446	448	418	383	369	338	345
Cash & Equivalents	90	85	136	94	100	78	46	45
Restricted Cash	31	54	52	60	55	56	31	51
Short-Term Investments	174	165	134	124	110	115	142	132
Note & Lease Receivable	0.51	0.58	0.71	0.49	-	-	-	-
Accounts Receivable	142	129	109	126	103	101	103	99
Inventories, net	8.08	7.84	6.63	6.76	7.37	7.00	6.95	7.30
Prepaid Expenses	8.94	4.89	8.79	6.75	7.56	11	8.21	10
Plant, Property, & Equipment, net	679	686	487	489	498	502	503	511
Plant, Property & Equipment, gross	1,288	1,283	1,073	1,066	1,102	1,097	1,088	1,076
Accumulated Depreciation	608	597	586	577	604	595	585	565
Total Noncurrent Assets	414	431	405	413	401	410	424	440
Long-Term Investments	144	144	137	136	110	113	121	121
Goodwill	170	170	168	168	168	168	168	168
Intangible Assets	20	20	7.04	7.04	7.04	7.04	7.04	7.04
Other Noncurrent Operating Assets	79	96	91	101	114	120	127	140
Other Noncurrent Nonoperating Assets	1.19	1.24	1.21	1.14	1.08	1.08	1.05	1.85
Total Liabilities & Shareholders' Equity	1,549	1,563	1,340	1,320	1,282	1,281	1,265	1,296
Total Liabilities	541	576	392	393	395	394	385	414
Total Current Liabilities	239	248	217	206	205	198	183	210
Short-Term Debt	7.50	7.50	0.00	0.00	2.13	3.39	-	4.91
Accounts Payable	36	42	40	41	32	30	30	35
Accrued Expenses	96	90	82	64	70	67	57	77
Dividends Payable	9.44	9.42	9.41	9.09	9.04	9.04	8.73	8.77
Other Current Liabilities	90	100	85	85	92	88	88	84
Total Noncurrent Liabilities	302	328	175	187	190	197	202	204
Long-Term Debt	127	140	-	-	-	-	-	-
Asset Retirement Reserve & Litigation Obligation	77	79	78	77	77	75	74	73
Noncurrent Deferred & Payable Income Tax Liabilities	37	31	23	20	9.85	12	12	9.75
Other Noncurrent Operating Liabilities	61	78	73	90	103	109	117	119
Total Equity & Noncontrolling Interests	1,008	987	948	927	887	886	880	881
Total Preferred & Common Equity	1,005	983	946	925	885	884	877	877
Total Common Equity	1,005	983	946	925	885	884	877	877
Common Stock	233	231	230	227	227	226	225	229
Retained Earnings	775	756	722	705	668	667	660	659
Accumulated Other Comprehensive Income / (Loss)	-3.33	-2.85	-5.91	-7.04	-10	-9.05	-7.85	-10
Noncontrolling Interest	3.09	3.33	2.03	1.77	2.17	2.44	2.80	4.02

This table displays calculated financial ratios and metrics derived from National HealthCare's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.53%	5.14%	1.06%	4.48%	3.20%	1.64%	1.71%	4.37%	1.87%	4.01%	10.49%
EBITDA Growth	27.29%	38.67%	-23.63%	-6.28%	-9.15%	10.00%	-0.36%	-1.70%	-2.58%	2.35%	-8.53%
EBIT Growth	42.90%	71.47%	-37.35%	-8.01%	-13.20%	14.90%	0.45%	-7.05%	-5.94%	0.10%	-16.62%
NOPAT Growth	52.68%	79.65%	-50.43%	22.39%	1.84%	-13.84%	8.76%	5.95%	-8.81%	-1.81%	-6.53%
Net Income Growth	56.36%	226.82%	-85.64%	231.24%	-38.23%	15.80%	5.42%	10.18%	-4.90%	-0.42%	-17.40%
EPS Growth	50.46%	199.31%	-83.87%	230.51%	-38.74%	14.73%	4.88%	11.14%	3.75%	1.91%	-18.86%
Operating Cash Flow Growth	-3.52%	1,172.20%	-85.99%	-69.30%	103.05%	1.69%	4.20%	3.94%	9.03%	1.73%	-19.94%
Free Cash Flow Firm Growth	-283.80%	283.60%	68.63%	-187.90%	272.85%	-19.86%	8.01%	147.57%	417.78%	128.21%	-139.27%
Invested Capital Growth	40.82%	-6.71%	13.74%	61.64%	-28.19%	-0.94%	-1.92%	-1.81%	4.47%	10.03%	17.30%
Revenue Q/Q Growth	5.52%	3.29%	-1.71%	-15.83%	29.08%	0.50%	0.35%	1.10%	0.11%	0.84%	2.30%
EBITDA Q/Q Growth	-5.48%	34.99%	-6.80%	20.91%	-18.92%	1.09%	3.08%	-0.83%	-1.97%	1.08%	0.65%
EBIT Q/Q Growth	-7.23%	63.75%	-12.99%	38.92%	-26.42%	1.41%	5.37%	-2.42%	-3.50%	1.03%	-1.04%
NOPAT Q/Q Growth	8.97%	26.54%	-1.69%	-4.54%	-11.03%	-1.06%	-8.52%	15.36%	-2.69%	-0.67%	-1.67%
Net Income Q/Q Growth	-17.69%	52.20%	-34.28%	-7.59%	48.58%	-6.14%	-5.11%	15.41%	-2.15%	1.78%	-4.55%
EPS Q/Q Growth	-18.27%	49.14%	-29.95%	-7.89%	50.28%	-6.33%	-5.15%	15.67%	-2.92%	3.56%	-3.38%
Operating Cash Flow Q/Q Growth	-10.76%	14.16%	-29.11%	-5.79%	-2.80%	4.00%	-2.09%	-2.71%	7.16%	-4.54%	16.84%
Free Cash Flow Firm Q/Q Growth	-27.62%	36.83%	7.11%	-6.46%	-5.13%	0.53%	12.31%	9.72%	83.08%	-78.49%	43.74%
Invested Capital Q/Q Growth	3.92%	-1.81%	0.54%	1.39%	0.19%	-0.73%	-0.58%	1.75%	1.46%	4.03%	0.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.97%	37.60%	36.80%	38.00%	39.61%	40.50%	40.56%	40.65%	40.66%	41.24%	41.46%
EBITDA Margin	11.28%	10.15%	7.69%	10.18%	11.35%	12.89%	11.91%	12.16%	12.91%	13.50%	13.72%
Operating Margin	6.56%	5.01%	2.94%	4.74%	4.68%	4.92%	5.72%	5.61%	6.56%	7.40%	7.80%
EBIT Margin	8.07%	6.46%	3.96%	6.39%	7.26%	8.64%	7.64%	7.73%	8.68%	9.41%	9.77%
Profit (Net Income) Margin	7.81%	5.72%	1.84%	12.95%	4.08%	6.82%	5.99%	5.78%	5.47%	5.86%	6.12%
Tax Burden Percent	74.84%	73.57%	73.36%	92.70%	80.10%	77.23%	78.39%	74.69%	63.01%	62.32%	62.64%
Interest Burden Percent	129.36%	120.25%	63.27%	218.40%	70.20%	102.30%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	25.16%	26.43%	26.64%	7.30%	19.90%	22.77%	21.61%	25.31%	36.99%	37.68%	37.36%
Return on Invested Capital (ROIC)	10.40%	7.92%	4.53%	12.08%	10.79%	9.06%	10.36%	9.35%	8.94%	10.50%	12.12%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.10%	1.51%	5.44%	-7.79%	10.00%	0.17%	5.36%	3.35%	3.39%	6.52%	9.13%
Return on Net Nonoperating Assets (RNNOA)	0.38%	-0.61%	-2.30%	4.22%	-5.47%	-0.08%	-2.20%	-1.24%	-1.17%	-2.71%	-4.62%
Return on Equity (ROE)	10.78%	7.30%	2.24%	16.30%	5.32%	8.98%	8.16%	8.11%	7.77%	7.79%	7.50%
Cash Return on Invested Capital (CROIC)	-23.50%	14.86%	-8.32%	-35.04%	43.60%	10.00%	12.30%	11.17%	4.57%	0.95%	-3.80%
Operating Return on Assets (OROA)	7.44%	5.71%	3.21%	4.97%	5.64%	7.27%	6.88%	6.83%	7.52%	8.05%	8.28%
Return on Assets (ROA)	7.20%	5.05%	1.49%	10.06%	3.17%	5.74%	5.39%	5.10%	4.74%	5.01%	5.19%
Return on Common Equity (ROCE)	10.76%	7.28%	2.23%	16.22%	5.31%	8.97%	8.15%	8.11%	7.77%	6.81%	5.71%
Return on Equity Simple (ROE_SIMPLE)	10.42%	7.18%	2.29%	15.40%	5.28%	8.73%	8.01%	7.92%	7.55%	8.42%	7.27%
Net Operating Profit after Tax (NOPAT)	64	42	23	47	39	38	44	40	38	42	43
NOPAT Margin	4.91%	3.68%	2.16%	4.39%	3.75%	3.80%	4.48%	4.19%	4.13%	4.61%	4.89%
Net Nonoperating Expense Percent (NNEP)	11.50%	6.41%	-0.91%	19.87%	0.79%	8.89%	5.00%	6.00%	5.54%	3.98%	2.99%
Return On Investment Capital (ROIC_SIMPLE)	5.73%	4.61%	2.65%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	62.03%	62.40%	63.20%	62.00%	60.40%	59.50%	59.44%	59.35%	59.34%	58.76%	58.54%
SG&A Expenses to Revenue	24.58%	25.25%	26.65%	24.83%	26.76%	26.94%	25.91%	25.92%	24.99%	25.05%	24.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	31.41%	32.59%	33.86%	33.26%	34.92%	35.58%	34.84%	35.04%	34.11%	33.84%	33.66%
Earnings before Interest and Taxes (EBIT)	105	74	43	69	75	86	75	75	80	85	85
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	147	116	84	109	117	128	117	117	119	122	120
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.69	1.52	0.99	1.07	1.15	1.47	1.38	1.08	1.37	1.13	0.00
Price to Tangible Book Value (P/TBV)	2.10	1.89	1.23	1.33	1.18	1.52	1.42	1.11	1.41	1.17	0.00
Price to Revenue (P/Rev)	1.27	1.21	0.79	0.90	0.89	1.15	1.03	0.79	0.99	0.79	0.00
Price to Earnings (P/E)	16.29	20.73	38.40	6.97	21.81	16.83	17.13	13.54	18.14	15.44	0.00
Dividend Yield	2.25%	2.59%	4.02%	3.37%	3.50%	2.75%	2.99%	3.77%	2.89%	3.21%	2.81%
Earnings Yield	6.14%	4.82%	2.60%	14.34%	4.58%	5.94%	5.84%	7.39%	5.51%	6.48%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.93	1.91	0.96	1.12	1.37	1.87	1.65	1.12	1.56	1.19	0.00
Enterprise Value to Revenue (EV/Rev)	1.07	0.86	0.49	0.50	0.40	0.78	0.70	0.50	0.73	0.55	0.00
Enterprise Value to EBITDA (EV/EBITDA)	9.46	8.46	6.34	4.94	3.52	6.07	5.92	4.10	5.69	4.07	0.00
Enterprise Value to EBIT (EV/EBIT)	13.22	13.29	12.30	7.86	5.50	9.06	9.23	6.45	8.46	5.84	0.00
Enterprise Value to NOPAT (EV/NOPAT)	21.72	23.32	22.62	11.43	10.65	20.58	15.72	11.90	17.79	11.91	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.99	8.82	60.55	8.65	2.02	7.79	7.02	5.09	7.47	5.98	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	12.43	0.00	0.00	2.64	18.64	13.25	9.96	34.79	132.21	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.14	0.00	0.01	0.00	0.02	0.04	0.11	0.18	0.22	0.24	0.06
Long-Term Debt to Equity	0.13	0.00	0.00	0.00	0.01	0.02	0.10	0.17	0.22	0.24	0.06
Financial Leverage	-0.35	-0.41	-0.42	-0.54	-0.55	-0.45	-0.41	-0.37	-0.34	-0.42	-0.51
Leverage Ratio	1.50	1.45	1.50	1.62	1.68	1.56	1.51	1.59	1.64	1.55	1.45
Compound Leverage Factor	1.94	1.74	0.95	3.54	1.18	1.60	1.51	1.59	1.64	1.55	1.45
Debt to Total Capital	12.23%	0.09%	0.66%	0.00%	1.84%	3.60%	9.61%	15.27%	18.32%	19.57%	5.97%
Short-Term Debt to Total Capital	0.67%	0.09%	0.56%	0.00%	0.54%	1.75%	0.48%	0.45%	0.42%	0.42%	0.40%
Long-Term Debt to Total Capital	11.56%	0.00%	0.10%	0.00%	1.30%	1.85%	9.12%	14.82%	17.90%	19.15%	5.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	21.84%
Noncontrolling Interests to Total Capital	0.27%	0.19%	0.37%	0.60%	0.38%	0.06%	0.15%	0.08%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.50%	99.72%	98.97%	99.40%	97.78%	96.34%	90.25%	84.65%	81.68%	80.43%	72.19%
Debt to EBITDA	0.93	0.01	0.07	0.00	0.13	0.23	0.67	1.08	1.26	1.25	0.39
Net Debt to EBITDA	-1.83	-3.50	-4.02	0.00	-4.33	-2.87	-2.74	-2.39	-2.00	-1.77	-2.99
Long-Term Debt to EBITDA	0.88	0.00	0.01	0.00	0.09	0.12	0.63	1.05	1.23	1.23	0.36
Debt to NOPAT	2.13	0.02	0.25	0.00	0.39	0.77	1.78	3.14	3.94	3.67	1.09
Net Debt to NOPAT	-4.20	-9.65	-14.35	0.00	-13.11	-9.75	-7.29	-6.94	-6.24	-5.19	-8.41
Long-Term Debt to NOPAT	2.02	0.00	0.04	0.00	0.27	0.40	1.69	3.04	3.85	3.59	1.02
Altman Z-Score	3.77	4.04	3.13	2.91	2.64	3.09	3.74	2.99	3.07	2.81	0.00
Noncontrolling Interest Sharing Ratio	0.25%	0.28%	0.49%	0.50%	0.23%	0.11%	0.13%	0.05%	0.00%	12.49%	23.98%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.81	1.89	1.79	1.62	1.62	1.75	2.04	2.12	1.93	1.85	1.76
Quick Ratio	1.65	1.55	1.43	1.52	1.47	1.53	1.90	1.98	1.66	1.59	1.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-145	79	-43	-137	156	42	52	48	20	3.77	-13
Operating Cash Flow to CapEx	420.80%	398.61%	33.59%	158.36%	1,344.04%	379.18%	386.44%	292.04%	145.18%	142.69%	153.74%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.92	0.88	0.81	0.78	0.78	0.84	0.90	0.88	0.87	0.86	0.85
Accounts Receivable Turnover	10.72	10.95	11.07	11.56	11.26	10.47	10.65	11.39	11.09	11.13	10.99
Inventory Turnover	98.74	98.43	87.58	76.72	76.56	79.52	79.70	78.04	72.70	72.51	71.50
Fixed Asset Turnover	2.22	2.28	2.11	2.06	1.95	1.86	1.81	1.74	1.69	1.73	1.79
Accounts Payable Turnover	20.69	20.02	18.63	17.16	17.35	16.97	16.83	16.59	15.14	14.10	13.89
Days Sales Outstanding (DSO)	34.04	33.34	32.96	31.56	32.42	34.85	34.26	32.05	32.93	32.80	33.23
Days Inventory Outstanding (DIO)	3.70	3.71	4.17	4.76	4.77	4.59	4.58	4.68	5.02	5.03	5.11
Days Payable Outstanding (DPO)	17.65	18.23	19.59	21.28	21.04	21.51	21.68	22.01	24.11	25.90	26.28
Cash Conversion Cycle (CCC)	20.09	18.82	17.54	15.04	16.15	17.93	17.16	14.73	13.84	11.94	12.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	722	513	549	483	299	416	420	428	436	417	379
Invested Capital Turnover	2.12	2.15	2.10	2.75	2.88	2.38	2.31	2.23	2.16	2.28	2.48
Increase / (Decrease) in Invested Capital	209	-37	66	184	-117	-3.93	-8.20	-7.87	19	38	56
Enterprise Value (EV)	1,394	980	529	540	411	779	691	481	679	498	0.00
Market Capitalization	1,661	1,385	862	967	913	1,148	1,010	761	917	715	0.00
Book Value per Share	$63.48	$59.30	$56.98	$58.55	$51.77	$50.83	$48.14	$46.24	$44.20	$42.33	$40.80
Tangible Book Value per Share	$51.15	$47.86	$45.55	$47.18	$50.38	$49.46	$46.76	$45.08	$43.04	$41.15	$39.52
Total Capital	1,120	911	883	908	813	808	813	830	820	785	781
Total Debt	137	0.86	5.85	0.00	15	29	78	127	150	154	47
Total Long-Term Debt	130	0.00	0.86	0.00	11	15	74	123	147	150	44
Net Debt	-270	-406	-336	-432	-506	-369	-320	-281	-238	-217	-358
Capital Expenditures (CapEx)	26	28	26	39	15	26	25	32	63	58	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-73	-88	-75	-151	-174	-72	-44	-48	-47	-50	-87
Debt-free Net Working Capital (DFNWC)	197	193	161	163	180	160	168	178	143	132	142
Net Working Capital (NWC)	190	192	156	163	176	146	164	174	140	128	139
Net Nonoperating Expense (NNE)	-38	-23	3.42	-92	-3.42	-30	-15	-15	-12	-11	-11
Net Nonoperating Obligations (NNO)	-261	-398	-328	-425	-499	-363	-314	-275	-234	-214	-355
Total Depreciation and Amortization (D&A)	42	42	40	41	42	42	42	43	39	37	34
Debt-free, Cash-free Net Working Capital to Revenue	-5.61%	-7.74%	-6.93%	-14.03%	-16.97%	-7.21%	-4.50%	-4.95%	-5.07%	-5.50%	-9.99%
Debt-free Net Working Capital to Revenue	15.08%	16.87%	14.83%	15.21%	17.50%	16.10%	17.14%	18.46%	15.53%	14.51%	16.30%
Net Working Capital to Revenue	14.50%	16.80%	14.37%	15.21%	17.07%	14.68%	16.74%	18.08%	15.15%	14.15%	15.94%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$6.62	$4.36	$1.46	$9.03	$2.74	$4.47	$3.87	$3.70	$3.34	$3.34	$3.24
Adjusted Weighted Average Basic Shares Outstanding	15.39M	15.31M	15.41M	15.35M	15.31M	15.27M	15.22M	15.19M	15.13M	13.89M	13.82M
Adjusted Diluted Earnings per Share	$6.53	$4.34	$1.45	$8.99	$2.72	$4.44	$3.87	$3.69	$3.32	$3.20	$3.14
Adjusted Weighted Average Diluted Shares Outstanding	15.60M	15.38M	15.45M	15.42M	15.37M	15.36M	15.24M	15.22M	15.21M	14.49M	14.22M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	15.45M	15.35M	15.36M	15.45M	15.37M	15.33M	15.26M	15.22M	15.18M	15.01M	14.11M
Normalized Net Operating Profit after Tax (NOPAT)	64	42	23	55	39	38	44	40	38	42	43
Normalized NOPAT Margin	4.91%	3.68%	2.16%	5.10%	3.75%	3.80%	4.48%	4.19%	4.13%	4.61%	4.89%
Pre Tax Income Margin	10.43%	7.77%	2.51%	13.97%	5.10%	8.83%	7.64%	7.73%	8.68%	9.41%	9.77%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	35.12%	54.47%	171.97%	23.72%	70.10%	46.60%	50.81%	50.71%	51.04%	56.59%	51.29%
Augmented Payout Ratio	48.34%	58.27%	221.54%	24.32%	70.22%	47.88%	52.29%	50.71%	67.26%	56.59%	64.40%

This table displays calculated financial ratios and metrics derived from National HealthCare's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	25.75%	22.74%	17.93%	6.40%	10.24%	13.74%	6.51%	4.14%	-3.38%	-6.66%	-2.13%
EBITDA Growth	43.44%	17.56%	31.67%	32.63%	30.83%	63.98%	59.75%	62.57%	-10.27%	-21.53%	-35.35%
EBIT Growth	63.14%	27.27%	47.59%	55.47%	48.69%	110.09%	151.46%	149.90%	-17.69%	-35.37%	-57.87%
NOPAT Growth	97.21%	72.30%	64.79%	67.35%	59.85%	125.51%	229.18%	257.00%	-32.35%	-2.13%	-68.05%
Net Income Growth	23.00%	-78.44%	321.90%	70.30%	132.62%	401.70%	425.75%	636.56%	-26.48%	-65.15%	12.38%
EPS Growth	22.49%	-79.35%	301.47%	63.21%	122.37%	348.78%	525.00%	404.76%	-23.23%	-60.19%	27.27%
Operating Cash Flow Growth	306.96%	-50.30%	5.89%	28.84%	-30.39%	115.63%	1,734.04%	49.84%	150.47%	-23.12%	-129.29%
Free Cash Flow Firm Growth	-542.50%	-450.07%	-564.09%	751.14%	695.63%	187.64%	150.35%	108.03%	101.98%	66.40%	60.28%
Invested Capital Growth	36.40%	40.82%	33.05%	-7.02%	-4.79%	-6.71%	-4.47%	0.68%	0.45%	13.74%	14.71%
Revenue Q/Q Growth	1.18%	8.57%	13.15%	1.17%	-1.24%	4.31%	2.09%	4.83%	1.89%	-2.32%	-0.19%
EBITDA Q/Q Growth	6.99%	19.34%	-2.51%	15.40%	-37.91%	33.66%	-1.80%	13.83%	280.27%	30.22%	-0.06%
EBIT Q/Q Growth	11.01%	24.21%	-8.03%	28.91%	-46.19%	44.05%	-3.12%	23.29%	452.56%	72.42%	-3.72%
NOPAT Q/Q Growth	-14.06%	70.76%	-7.16%	45.18%	-25.14%	63.31%	-5.71%	38.67%	5.61%	138.38%	2.26%
Net Income Q/Q Growth	435.58%	-85.88%	57.53%	3.26%	-6.13%	176.31%	-36.41%	41.05%	102.46%	279.40%	-243.78%
EPS Q/Q Growth	444.74%	-86.08%	57.80%	2.37%	-8.15%	170.59%	-35.85%	39.47%	85.37%	356.25%	-176.19%
Operating Cash Flow Q/Q Growth	206.94%	-62.61%	-32.48%	425.20%	-62.52%	-20.34%	-17.84%	183.76%	16.11%	703.64%	-107.53%
Free Cash Flow Firm Q/Q Growth	8.70%	-16.37%	-389.70%	43.90%	-27.84%	54.27%	431.30%	34.51%	107.95%	11.37%	15.24%
Invested Capital Q/Q Growth	-1.58%	3.92%	39.80%	-4.60%	1.60%	-1.81%	-2.31%	-2.31%	-0.45%	0.54%	2.96%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	38.95%	36.56%	37.27%	40.11%	38.37%	38.00%	36.68%	37.97%	37.74%	36.75%	36.05%
EBITDA Margin	12.26%	11.60%	10.55%	12.24%	10.73%	12.11%	9.45%	9.82%	9.05%	8.40%	6.30%
Operating Margin	8.23%	7.19%	6.19%	7.49%	5.26%	6.69%	4.52%	4.95%	3.71%	3.42%	1.51%
EBIT Margin	9.32%	8.50%	7.43%	9.14%	7.17%	8.20%	5.94%	6.25%	5.32%	4.44%	2.51%
Profit (Net Income) Margin	8.64%	1.63%	12.55%	9.02%	8.83%	9.29%	3.51%	5.63%	4.19%	2.11%	-1.15%
Tax Burden Percent	73.85%	99.54%	73.57%	74.06%	73.51%	76.27%	72.14%	71.30%	71.78%	75.19%	73.16%
Interest Burden Percent	125.47%	19.30%	229.66%	133.21%	167.56%	148.66%	81.94%	126.31%	109.67%	63.14%	-62.37%
Effective Tax Rate	26.15%	0.46%	26.43%	25.94%	26.49%	23.73%	27.86%	28.70%	28.22%	24.81%	0.00%
Return on Invested Capital (ROIC)	13.67%	15.17%	9.27%	12.77%	8.47%	10.96%	6.74%	7.20%	5.26%	5.41%	2.28%
ROIC Less NNEP Spread (ROIC-NNEP)	10.95%	21.36%	0.99%	10.18%	4.47%	7.49%	6.53%	5.56%	4.09%	5.74%	3.84%
Return on Net Nonoperating Assets (RNNOA)	-3.98%	-7.44%	-0.35%	-4.46%	-1.83%	-3.04%	-2.59%	-2.25%	-1.60%	-2.42%	-1.64%
Return on Equity (ROE)	9.69%	7.73%	8.92%	8.32%	6.64%	7.92%	4.15%	4.95%	3.66%	2.99%	0.64%
Cash Return on Invested Capital (CROIC)	-18.53%	-23.50%	-18.68%	17.56%	13.58%	14.86%	10.79%	4.34%	3.15%	-8.32%	-9.05%
Operating Return on Assets (OROA)	9.00%	7.84%	6.47%	8.28%	6.49%	7.24%	5.09%	5.17%	4.37%	3.60%	2.05%
Return on Assets (ROA)	8.34%	1.51%	10.93%	8.17%	7.99%	8.20%	3.01%	4.66%	3.44%	1.71%	-0.93%
Return on Common Equity (ROCE)	9.66%	7.71%	8.90%	8.30%	6.62%	7.90%	4.14%	4.93%	3.64%	2.98%	0.63%
Return on Equity Simple (ROE_SIMPLE)	10.76%	0.00%	12.61%	9.67%	8.68%	0.00%	4.85%	3.36%	1.81%	0.00%	3.46%
Net Operating Profit after Tax (NOPAT)	23	26	15	17	11	15	9.40	9.97	7.19	6.80	2.85
NOPAT Margin	6.08%	7.16%	4.55%	5.55%	3.87%	5.10%	3.26%	3.53%	2.67%	2.57%	1.05%
Net Nonoperating Expense Percent (NNEP)	2.72%	-6.19%	8.28%	2.60%	4.00%	3.48%	0.21%	1.64%	1.17%	-0.33%	-1.57%
Return On Investment Capital (ROIC_SIMPLE)	1.99%	2.36%	-	-	-	1.68%	-	-	-	0.77%	-
Cost of Revenue to Revenue	61.05%	63.44%	62.73%	59.89%	61.63%	62.00%	63.32%	62.03%	62.26%	63.25%	63.95%
SG&A Expenses to Revenue	24.74%	22.55%	24.25%	25.99%	26.05%	23.58%	25.13%	25.92%	26.52%	26.87%	26.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.72%	29.37%	31.09%	32.62%	33.11%	31.32%	32.17%	33.02%	34.03%	33.32%	34.55%
Earnings before Interest and Taxes (EBIT)	35	31	25	27	21	25	17	18	14	12	6.81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	46	43	36	37	32	36	27	28	24	22	17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.43	1.69	1.97	1.77	1.56	1.52	1.08	1.04	0.98	0.99	1.06
Price to Tangible Book Value (P/TBV)	1.76	2.10	2.44	2.17	1.92	1.89	1.35	1.30	1.22	1.23	1.32
Price to Revenue (P/Rev)	1.04	1.27	1.57	1.41	1.23	1.21	0.87	0.85	0.80	0.79	0.84
Price to Earnings (P/E)	13.28	16.29	15.61	18.17	17.72	20.73	21.40	28.86	45.58	38.40	29.08
Dividend Yield	2.63%	2.25%	1.91%	2.20%	2.51%	2.59%	3.71%	3.82%	4.07%	4.02%	3.74%
Earnings Yield	7.53%	6.14%	6.41%	5.50%	5.64%	4.82%	4.67%	3.47%	2.19%	2.60%	3.44%
Enterprise Value to Invested Capital (EV/IC)	1.59	1.93	2.37	2.44	1.97	1.91	1.12	1.06	0.95	0.96	1.08
Enterprise Value to Revenue (EV/Rev)	0.82	1.07	1.33	1.02	0.88	0.86	0.53	0.52	0.48	0.49	0.53
Enterprise Value to EBITDA (EV/EBITDA)	7.01	9.46	10.53	8.23	7.43	8.46	6.84	7.46	8.03	6.34	6.58
Enterprise Value to EBIT (EV/EBIT)	9.51	13.22	14.45	11.49	10.74	13.29	13.02	16.23	21.59	12.30	11.92
Enterprise Value to NOPAT (EV/NOPAT)	14.97	21.72	27.89	22.87	22.20	23.32	17.66	21.10	26.52	22.62	24.76
Enterprise Value to Operating Cash Flow (EV/OCF)	8.26	12.99	13.66	10.24	9.61	8.82	6.02	8.93	10.42	60.55	47.79
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	13.39	14.18	12.43	10.17	24.38	30.29	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.14	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01
Long-Term Debt to Equity	0.13	0.13	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.36	-0.35	-0.35	-0.44	-0.41	-0.41	-0.40	-0.40	-0.39	-0.42	-0.43
Leverage Ratio	1.48	1.50	1.52	1.43	1.43	1.45	1.46	1.47	1.46	1.50	1.52
Compound Leverage Factor	1.86	0.29	3.49	1.90	2.40	2.15	1.19	1.86	1.61	0.95	-0.95
Debt to Total Capital	11.73%	12.23%	12.97%	0.00%	0.00%	0.09%	0.24%	0.38%	0.00%	0.66%	0.79%
Short-Term Debt to Total Capital	0.66%	0.67%	0.66%	0.00%	0.00%	0.09%	0.24%	0.38%	0.00%	0.56%	0.55%
Long-Term Debt to Total Capital	11.08%	11.56%	12.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	0.24%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.27%	0.27%	0.29%	0.21%	0.19%	0.19%	0.24%	0.27%	0.32%	0.37%	0.45%
Common Equity to Total Capital	88.00%	87.50%	86.74%	99.79%	99.81%	99.72%	99.52%	99.35%	99.68%	98.97%	98.75%
Debt to EBITDA	0.83	0.93	0.94	0.00	0.00	0.01	0.02	0.04	0.00	0.07	0.08
Net Debt to EBITDA	-1.90	-1.83	-1.93	0.00	0.00	-3.50	-4.35	-4.76	0.00	-4.02	-3.81
Long-Term Debt to EBITDA	0.78	0.88	0.89	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.02
Debt to NOPAT	1.77	2.13	2.50	0.00	0.00	0.02	0.06	0.13	0.00	0.25	0.30
Net Debt to NOPAT	-4.05	-4.20	-5.10	0.00	0.00	-9.65	-11.24	-13.47	0.00	-14.35	-14.36
Long-Term Debt to NOPAT	1.68	2.02	2.37	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.09
Altman Z-Score	3.43	3.61	3.70	4.47	4.08	3.92	3.26	3.19	3.10	3.05	3.05
Noncontrolling Interest Sharing Ratio	0.25%	0.25%	0.29%	0.24%	0.25%	0.28%	0.35%	0.40%	0.48%	0.49%	0.57%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.90	1.81	1.80	2.06	2.02	1.89	1.87	1.86	1.84	1.79	1.64
Quick Ratio	1.70	1.65	1.53	1.75	1.66	1.55	1.53	1.49	1.59	1.43	1.31
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-167	-183	-157	54	38	52	34	6.37	4.73	-60	-67
Operating Cash Flow to CapEx	639.64%	156.80%	604.79%	646.76%	161.98%	299.19%	496.16%	639.47%	208.69%	211.71%	-26.26%
Free Cash Flow to Firm to Interest Expense	-79.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	18.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	15.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.96	0.92	0.87	0.91	0.90	0.88	0.86	0.83	0.82	0.81	0.81
Accounts Receivable Turnover	10.35	10.72	10.71	11.27	10.22	10.95	10.96	10.79	10.51	11.07	11.16
Inventory Turnover	115.34	98.74	100.33	107.50	106.16	98.43	94.49	95.23	87.99	87.58	87.74
Fixed Asset Turnover	2.37	2.22	2.09	2.40	2.36	2.28	2.19	2.14	2.10	2.11	2.14
Accounts Payable Turnover	22.46	20.69	20.74	20.87	20.70	20.02	20.69	18.39	18.78	18.63	16.53
Days Sales Outstanding (DSO)	35.26	34.04	34.08	32.38	35.71	33.34	33.29	33.84	34.74	32.96	32.72
Days Inventory Outstanding (DIO)	3.16	3.70	3.64	3.40	3.44	3.71	3.86	3.83	4.15	4.17	4.16
Days Payable Outstanding (DPO)	16.25	17.65	17.60	17.49	17.63	18.23	17.64	19.84	19.44	19.59	22.08
Cash Conversion Cycle (CCC)	22.17	20.09	20.12	18.29	21.52	18.82	19.51	17.83	19.45	17.54	14.80
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	710	722	695	497	521	513	522	534	547	549	546
Invested Capital Turnover	2.25	2.12	2.04	2.30	2.19	2.15	2.07	2.04	1.97	2.10	2.16
Increase / (Decrease) in Invested Capital	190	209	173	-38	-26	-37	-24	3.60	2.45	66	70
Enterprise Value (EV)	1,130	1,394	1,643	1,212	1,028	980	587	564	521	529	589
Market Capitalization	1,433	1,661	1,940	1,669	1,440	1,385	958	921	859	862	927
Book Value per Share	$65.06	$63.48	$63.76	$61.42	$60.24	$59.30	$57.78	$57.70	$57.12	$56.98	$56.65
Tangible Book Value per Share	$52.74	$51.15	$51.48	$50.03	$48.82	$47.86	$46.33	$46.25	$45.70	$45.55	$45.32
Total Capital	1,142	1,120	1,134	948	927	911	889	890	880	883	888
Total Debt	134	137	147	0.00	0.00	0.86	2.13	3.39	0.00	5.85	7.05
Total Long-Term Debt	127	130	140	0.00	0.00	0.00	0.00	0.00	0.00	0.86	2.13
Net Debt	-306	-270	-300	-459	-414	-406	-373	-360	-341	-336	-342
Capital Expenditures (CapEx)	6.14	8.16	5.66	7.83	5.96	8.60	6.51	6.15	6.64	5.64	7.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-72	-73	-98	-91	-67	-88	-85	-76	-65	-75	-89
Debt-free Net Working Capital (DFNWC)	223	197	205	231	211	193	180	174	155	161	139
Net Working Capital (NWC)	216	190	198	231	211	192	178	171	155	156	134
Net Nonoperating Expense (NNE)	-9.57	20	-27	-10	-15	-13	-0.72	-5.95	-4.10	1.23	5.96
Net Nonoperating Obligations (NNO)	-298	-261	-292	-451	-406	-398	-365	-352	-333	-328	-335
Total Depreciation and Amortization (D&A)	11	11	11	9.34	11	12	10	10	10	10	10
Debt-free, Cash-free Net Working Capital to Revenue	-5.24%	-5.61%	-7.94%	-7.70%	-5.71%	-7.74%	-7.69%	-6.95%	-6.03%	-6.93%	-8.02%
Debt-free Net Working Capital to Revenue	16.15%	15.08%	16.57%	19.45%	18.06%	16.87%	16.29%	16.03%	14.37%	14.83%	12.61%
Net Working Capital to Revenue	15.61%	14.50%	15.96%	19.45%	18.06%	16.80%	16.10%	15.72%	14.37%	14.37%	12.16%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.09	$0.39	$2.78	$1.74	$1.71	$1.86	$0.68	$1.06	$0.76	$0.42	($0.16)
Adjusted Weighted Average Basic Shares Outstanding	15.44M	15.39M	15.41M	15.39M	15.35M	15.31M	15.30M	15.30M	15.34M	15.41M	15.45M
Adjusted Diluted Earnings per Share	$2.07	$0.38	$2.73	$1.73	$1.69	$1.84	$0.68	$1.06	$0.76	$0.41	($0.16)
Adjusted Weighted Average Diluted Shares Outstanding	15.58M	15.60M	15.67M	15.56M	15.51M	15.38M	15.32M	15.32M	15.36M	15.45M	15.45M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	15.47M	15.45M	15.44M	15.42M	15.40M	15.35M	15.32M	15.32M	15.32M	15.36M	15.34M
Normalized Net Operating Profit after Tax (NOPAT)	23	26	15	17	11	15	9.40	9.97	7.19	6.80	2.85
Normalized NOPAT Margin	6.08%	7.16%	4.55%	5.55%	3.87%	5.10%	3.26%	3.53%	2.67%	2.57%	1.05%
Pre Tax Income Margin	11.70%	1.64%	17.06%	12.17%	12.02%	12.18%	4.86%	7.90%	5.83%	2.80%	-1.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	16.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	10.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	13.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	7.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	33.50%	35.12%	28.38%	39.61%	44.69%	54.47%	82.28%	118.25%	219.06%	171.97%	113.70%
Augmented Payout Ratio	38.42%	48.34%	39.27%	52.07%	57.02%	58.27%	95.05%	159.50%	295.97%	221.54%	138.26%

Frequently Asked Questions About National HealthCare's Financials

When does National HealthCare's fiscal year end?

According to the most recent income statement we have on file, National HealthCare's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has National HealthCare's net income changed over the last 10 years?

National HealthCare's net income appears to be on an upward trend, with a most recent value of $102.09 million in 2024, rising from $53.37 million in 2014. The previous period was $65.29 million in 2023.

What is National HealthCare's operating income?

National HealthCare's total operating income in 2024 was $85.76 million, based on the following breakdown:

Total Gross Profit: $496.45 million
Total Operating Expenses: $410.69 million

How has National HealthCare revenue changed over the last 10 years?

Over the last 10 years, National HealthCare's total revenue changed from $871.68 million in 2014 to $1.31 billion in 2024, a change of 50.0%.

How much debt does National HealthCare have?

National HealthCare's total liabilities were at $541.27 million at the end of 2024, a 35.2% increase from 2023, and a 59.2% increase since 2014.

How much cash does National HealthCare have?

In the past 10 years, National HealthCare's cash and equivalents has ranged from $26.34 million in 2016 to $147.09 million in 2020, and is currently $76.12 million as of their latest financial filing in 2024.

How has National HealthCare's book value per share changed over the last 10 years?

Over the last 10 years, National HealthCare's book value per share changed from 40.80 in 2014 to 63.48 in 2024, a change of 55.6%.

Related Companies

This page (NYSEAMERICAN:NHC) was last updated on 5/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National HealthCare (NHC) Financials

Frequently Asked Questions About National HealthCare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

National HealthCare (NHC) Financials

Annual Income Statements for National HealthCare

Quarterly Income Statements for National HealthCare

Annual Cash Flow Statements for National HealthCare

Quarterly Cash Flow Statements for National HealthCare

Annual Balance Sheets for National HealthCare

Quarterly Balance Sheets for National HealthCare

Annual Metrics And Ratios for National HealthCare

Quarterly Metrics And Ratios for National HealthCare

Frequently Asked Questions About National HealthCare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools